CA50785-5B - 0x0000000000006BED

Healthy Males & Females

Forward

* Stipend may pay up to reflected amount.
Start Date: 
September 9, 2026 - 3:15pm
End Date: 
September 17, 2026 - 9:45am

Study Details

Study Number: CA50785
Group Number: 5B
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,250.00

Study Criteria

Age: 19 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 111 lbs

Study Information

Indication: This investigational medication is being developed for the treatment of multiple sclerosis (MS).
Route of Administration: Oral
Blood Draws: 16

Study Schedule

Schedule Type: Short stays with returns
Study Length: 3 Night Stay & 2 Returns

Screening Dates:

Event Day Event Date
Monday 8/24/2026
Thursday 8/27/2026
Monday 8/31/2026
Tuesday 9/1/2026

Doctor Exam Dates:

Event Day Event Date
Monday 8/24/2026
Thursday 8/27/2026
Monday 8/31/2026
Tuesday 9/1/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Wednesday 9/9/2026 3:15:00 PM Saturday 9/12/2026 9:45:00 AM 1 Lincoln
Return Monday 9/14/2026 8:45:00 AM Monday 9/14/2026 9:45:00 AM 1 Lincoln
Return Thursday 9/17/2026 8:45:00 AM Thursday 9/17/2026 9:45:00 AM 1 Lincoln